Skip to content
Screener

HealthEquity HQY Q3 2026 earnings

Reported December 3, 2025 · After market close

Revenue$322.2MBeat by $1.5M
EPS$1.01Beat by $0.10
Revenue estimate$320.6M
EPS estimate$0.91

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$322.2M+7.2%
Gross profit$228.1M+15.8%
Operating income$78.7M+301%
Net income$51.7M+806%
EPS (diluted)$0.59+883%

Balance sheet

See full
Cash & equivalents$309.3M-4.0%
Total debt$1.0B-9.4%
Total equity$2.1B+0.4%
Total assets$3.4B-2.6%

Cash flow

See full
Operating cash flow$138.6M+53.0%
CapEx$784.0K+167%
Free cash flow$137.8M+52.7%

Valuation & ratios

Valuation

as of 10/31/25
See full
Market cap$8.15B+9.7%
Enterprise value$8.87B+7.6%
P/E42.5×-34.3×
P/S6.3×-0.1×

Profitability

See full
Gross margin67.7%+2.4pp
Operating margin22.7%+8.9pp
Net margin14.9%+6.5pp
FCF margin32%+2.5pp

Returns & leverage

See full
Return on equity9%+4.3pp
Debt / equity0.5×-0.1×
Current ratio4.1×+0.9×

Segments

By product

See full
Custodial revenue$159.1M+12.9%
Service revenue$120.3M+0.9%
Interchange revenue$42.8M+6.2%

FAQ

When did HealthEquity report Q3 2026 earnings?
HealthEquity (HQY) reported Q3 2026 earnings on December 3, 2025 after market close.
What were HealthEquity's Q3 2026 revenue and EPS?
HealthEquity reported revenue of $322.2M and eps of $1.01 for Q3 2026.
Did HealthEquity beat estimates in Q3 2026?
Revenue beat the consensus estimate of $320.6M by $1.5M. EPS beat the consensus estimate of $0.91 by $0.10.
How did HealthEquity's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.2% from $300.4M a year earlier and eps grew 29.5% from $0.78.
Where can I find HealthEquity's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001428336-25-000035) and the 10-Q periodic report (0001428336-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.